RÉSEAU P&P provides daily support to pharmacy owners through a dedicated concierge service, focusing on optimizing operations and improving margins, self-described as innovative.

RÉSEAU P&P

CPS Solutions, LLC provides pharmacy solutions focused on improving patient outcomes and financial results for health systems. This includes services such as specialty pharmacy, pharmacy management, telepharmacy, consulting, rehabilitation, and supply chain. The company has been serving hospitals for over 50 years.

CPS Solutions, LLC

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Metric
Company Name	RÉSEAU P&P	CPS Solutions, LLC	McKesson Corporation
Symbol			MCK
MSH ID	COM:RESEAU-PNP	COM:CPS	COM:MCKESSON
Market	PRIVATE	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare
Industry	Pharmaceutical Services	Pharmaceuticals and Healthcare Services	Medical - Distribution
Country	FR	US	US
Stage
Employee Count			45K
Website	reseau-pnp.com	cps.com	mckesson.com
LinkedIn
Founders

Metric
Market Cap			76.12B
Enterprise Value
Monthly Web Traffic			2.42M
Web Traffic Growth			0.03
Valuation
Raised Capital

Metric
Revenue			308.95B
Revenue (LTM)
Revenue (NTM)
Gross Profit			12.20B
EBITDA			4.56B
Operating Income			3.93B
Net Income			3.00B
EPS			22.54
Diluted EPS			22.39
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin			0.04
Operating Profit Margin			0.01
EBITDA Margin			0.01
Net Profit Margin			0.01
Return on Equity			7.32
Return on Assets			0.05
Return on Capital Employed			0.27

RESE

COM:RESEAU-PNP

RÉSEAU P&P

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			19.52
P/B Ratio			-37.24
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio			0.26
EV Multiple			16.72

Metric
Days Sales Outstanding			28.20
Days Payables Outstanding			61.27
Days Inventory Outstanding			31.00
Operating Cycle			58.62
Cash Conversion Cycle			-3.22
Asset Turnover			4.58

Metric
Operating Cash Flow			4.31B
Free Cash Flow			3.63B
Cash Flow to Debt			0.75
Operating Cash Flow/Sales			0.01
Free Cash Flow Yield			0.06

Metric
Cash & Equivalents			4.58B
Accounts Receivable			-2.95B
Inventory			21.14B
Goodwill			10.13B
Debt to Capitalization			1.52
Debt to Assets			0.11
Current Ratio			0.93
Quick Ratio			0.51

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue			0.00
R&D to Revenue
SG&A to Revenue			0.05